Skip to main content
. 2019 Feb 12;8(4):e010694. doi: 10.1161/JAHA.118.010694

Table 1.

Subject Characteristics by FD Status

Total (N=4944) Non–Food Desert (N=3963) Food Desert (N=981) P Value
Age, y 64±12 64±12 63±12 0.006a
Male 3148 (64) 2540 (64) 608 (62) 0.22
Black race 1087 (22) 787 (20) 300 (31) <0.001a
Education <0.001a
High school graduate or less 2104 (43) 1628 (41) 476 (49)
Some college 1108 (22) 883 (22) 225 (23)
College graduate 1732 (35) 1452 (37) 280 (29)
Urban 2846 (74) 2243 (73) 603 (77) 0.023a
Hypertension 3913 (79) 3110 (79) 803 (82) 0.028a
Diabetes mellitus 1748 (36) 1399 (36) 349 (36) 0.86
Hyperlipidemia 3537 (72) 2848 (72) 689 (71) 0.32
Smoking 3393 (69) 2723 (69) 670 (68) 0.82
History of coronary artery disease 4500 (91) 3610 (91) 890 (91) 0.71
History of myocardial infarction 1178 (24) 957 (25) 221 (23) 0.36
History of revascularization 2637 (53) 2143 (54) 494 (50) 0.038a
History of heart failure 956 (19) 764 (19) 192 (20) 0.86
BMI, kg/m2 30±6 29±6 30±7 0.002a
Total cholesterol, mg/dL 166±45 166±44 166±47 0.65
LDL, mg/dL 94±38 94±37 96±39 0.11
HDL, mg/dL 43±16 43±14 43±23 0.9
eGFR, mL/min per 1.73 m2 73±24 73±24 72±26 0.62
Gensini angiographic score, median (IQR) 6.5 (0–32) 6.5 (0–33) 7 (0–31) 0.9
Ejection fraction % 53±13 53±13 52±13 0.24
Medications
ACE/ARB use 2757 (56) 2235 (56) 522 (53) 0.07
Aspirin use 3762 (76) 3038 (77) 724 (74) 0.07
Clopidogrel use 2215 (45) 1779 (45) 436 (44) 0.83
Statin use 3471 (70) 2805 (71) 666 (68) 0.08
β‐Blocker use 3340 (68) 2687 (68) 653 (67) 0.47

Values shown are mean±SDs or median (IQR) for continuous variables and number (percentage) for categorical variables. ACE indicates angiotensin‐converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BMI, body mass index; eGFR, estimated glomerular filtration rate; FD, food deserts; HDL, high‐density lipoprotein cholesterol; IQR, interquartile range; LDL, low‐density lipoprotein cholesterol.

a

Denotes a statistically significant P‐value.